{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T14:54:15Z","timestamp":1761058455903},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2006,5,20]],"date-time":"2006-05-20T00:00:00Z","timestamp":1148083200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Graefe's Arch Clin Exp Ophthalmo"],"published-print":{"date-parts":[[2006,11,8]]},"DOI":"10.1007\/s00417-006-0326-2","type":"journal-article","created":{"date-parts":[[2006,5,19]],"date-time":"2006-05-19T09:11:19Z","timestamp":1148029879000},"page":"1385-1390","source":"Crossref","is-referenced-by-count":6,"title":["Carboxymethylcellulose as a new carrier substance for intravitreal injection of reproducible amounts of triamcinolone"],"prefix":"10.1007","volume":"244","author":[{"given":"T.","family":"Kube","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Sutter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Trittler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N.","family":"Feltgen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L. L.","family":"Hansen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H. T.","family":"Agostini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2006,5,20]]},"reference":[{"key":"326_CR1","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1097\/00006982-200302000-00022","volume":"23","author":"CD Alldredge","year":"2003","unstructured":"Alldredge CD, Garretson BR (2003) Intravitreal triamcinolone for the treatment of idiopathic juxtafoveal telangiectasis. Retina 23:113\u2013116","journal-title":"Retina"},{"key":"326_CR2","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1016\/S0161-6420(00)00658-8","volume":"108","author":"RJ Antcliff","year":"2001","unstructured":"Antcliff RJ, Spalton DJ, Stanford MR, Graham EM, Ffytche TJ, Marshall J (2001) Intravitreal triamcinolone for uveitic cystoid macular edema: an optical coherence tomography study. Ophthalmology 108:765\u2013772","journal-title":"Ophthalmology"},{"key":"326_CR3","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/S0161-6420(02)01969-3","volume":"110","author":"PM Beer","year":"2003","unstructured":"Beer PM, Bakri SJ, Singh RJ, Liu W, Peters GB 3rd, Miller M (2003) Intraocular concentration and pharmacokinetics of triamcinolone acetonide after a single intravitreal injection. Ophthalmology 110:681\u2013686","journal-title":"Ophthalmology"},{"key":"326_CR4","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/S0002-9394(02)01938-4","volume":"135","author":"N Benhamou","year":"2003","unstructured":"Benhamou N, Massin P, Haouchine B, Audren F, Tadayoni R, Gaudric A (2003) Intravitreal triamcinolone for refractory pseudophakic macular edema. Am J Ophthalmol 135:246\u2013249","journal-title":"Am J Ophthalmol"},{"key":"326_CR5","first-page":"492","volume":"46","author":"GK Berry","year":"2005","unstructured":"Berry GK, Reed JB (2005) The effect of sedimentation on the concentration of triamcinolone acetonide. Invest Ophthalmol Vis Sci 46:492\u2013","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"326_CR6","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/S0886-3350(03)00016-6","volume":"29","author":"SE Burk","year":"2003","unstructured":"Burk SE, Da Mata AP, Snyder ME, Schneider S, Osher RH, Cionni RJ (2003) Visualizing vitreous using Kenalog suspension. J Cataract Refract Surg 29:645\u2013651","journal-title":"J Cataract Refract Surg"},{"key":"326_CR7","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/S0002-9394(02)02030-5","volume":"135","author":"LA Bynoe","year":"2003","unstructured":"Bynoe LA, Weiss JN (2003) Retinal endovascular surgery and intravitreal triamcinolone acetonide for central vein occlusion in young adults. Am J Ophthalmol 135:382\u2013384","journal-title":"Am J Ophthalmol"},{"key":"326_CR8","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1111\/j.1442-9071.1998.tb01330.x","volume":"26","author":"JK Challa","year":"1998","unstructured":"Challa JK, Gillies MC, Penfold PL, Gyory JF, Hunyor AB, Billson FA (1998) Exudative macular degeneration and intravitreal triamcinolone: 18\u00a0month follow up. Aust N Z J Ophthalmol 26:277\u2013281","journal-title":"Aust N Z J Ophthalmol"},{"key":"326_CR9","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/S0886-3350(02)01441-4","volume":"29","author":"MD Conway","year":"2003","unstructured":"Conway MD, Canakis C, Livir-Rallatos C, Peyman GA (2003) Intravitreal triamcinolone acetonide for refractory chronic pseudophakic cystoid macular edema. J Cataract Refract Surg 29:27\u201333","journal-title":"J Cataract Refract Surg"},{"key":"326_CR10","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1097\/00006982-200003000-00004","volume":"20","author":"RP Danis","year":"2000","unstructured":"Danis RP, Ciulla TA, Pratt LM, Anliker W (2000) Intravitreal triamcinolone acetonide in exudative age-related macular degeneration. Retina 20:244\u2013250","journal-title":"Retina"},{"key":"326_CR11","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1136\/bjo.87.3.361","volume":"87","author":"RF Degenring","year":"2003","unstructured":"Degenring RF, Jonas JB (2003) Intravitreal injection of triamcinolone acetonide as treatment for chronic uveitis. Br J Ophthalmol 87:361","journal-title":"Br J Ophthalmol"},{"key":"326_CR12","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1034\/j.1600-0420.2003.00176.x","volume":"81","author":"RF Degenring","year":"2003","unstructured":"Degenring RF, Kamppeter B, Kreissig I, Jonas JB (2003) Morphological and functional changes after intravitreal triamcinolone acetonide for retinal vein occlusion. Acta Ophthalmol Scand 81:548\u2013550","journal-title":"Acta Ophthalmol Scand"},{"key":"326_CR13","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/S0886-3350(89)80009-4","volume":"15","author":"J Fernandez-Vigo","year":"1989","unstructured":"Fernandez-Vigo J, Refojo MF, Jumblatt M (1989) Elimination of hydroxypropyl methylcellulose from the anterior chamber of the rabbit. J Cataract Refract Surg 15:191\u2013195","journal-title":"J Cataract Refract Surg"},{"key":"326_CR14","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1097\/00006982-199004000-00012","volume":"10","author":"J Fernandez-Vigo","year":"1990","unstructured":"Fernandez-Vigo J, Refojo MF, Verstraeten T (1990) Evaluation of a viscoelastic solution of hydroxypropyl methylcellulose as a potential vitreous substitute. Retina 10:148\u2013152","journal-title":"Retina"},{"key":"326_CR15","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1001\/archopht.121.5.667","volume":"121","author":"MC Gillies","year":"2003","unstructured":"Gillies MC, Simpson JM, Luo W, Penfold P, Hunyor AB, Chua W, Mitchell P, Billson F (2003) A randomized clinical trial of a single dose of intravitreal triamcinolone acetonide for neovascular age-related macular degeneration: one-year results. Arch Ophthalmol 121:667\u2013673","journal-title":"Arch Ophthalmol"},{"key":"326_CR16","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1136\/bjo.86.2.247","volume":"86","author":"PB Greenberg","year":"2002","unstructured":"Greenberg PB, Martidis A, Rogers AH, Duker JS, Reichel E (2002) Intravitreal triamcinolone acetonide for macular oedema due to central retinal vein occlusion. Br J Ophthalmol 86:247\u2013248","journal-title":"Br J Ophthalmol"},{"key":"326_CR17","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/0002-9394(86)90593-3","volume":"101","author":"T Hida","year":"1986","unstructured":"Hida T, Chandler D, Arena JE, Machemer R (1986) Experimental and clinical observations of the intraocular toxicity of commercial corticosteroid preparations. Am J Ophthalmol 101:190\u2013195","journal-title":"Am J Ophthalmol"},{"key":"326_CR18","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1076\/soph.18.2.67.15860","volume":"18","author":"M Ip","year":"2003","unstructured":"Ip M, Kahana A, Altaweel M (2003) Treatment of central retinal vein occlusion with triamcinolone acetonide: an optical coherence tomography study. Semin Ophthalmol 18:67\u201373","journal-title":"Semin Ophthalmol"},{"key":"326_CR19","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1136\/bjo.86.9.1066","volume":"86","author":"JB Jonas","year":"2002","unstructured":"Jonas JB (2002) Concentration of intravitreally injected triamcinolone acetonide in aqueous humour. Br J Ophthalmol 86:1066","journal-title":"Br J Ophthalmol"},{"key":"326_CR20","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/S0002-9394(01)01010-8","volume":"132","author":"JB Jonas","year":"2001","unstructured":"Jonas JB, Sofker A (2001) Intraocular injection of crystalline cortisone as adjunctive treatment of diabetic macular edema. Am J Ophthalmol 132:425\u2013427","journal-title":"Am J Ophthalmol"},{"key":"326_CR21","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1136\/bjo.84.9.1064","volume":"84","author":"JB Jonas","year":"2000","unstructured":"Jonas JB, Hayler JK, Panda-Jonas S (2000) Intravitreal injection of crystalline cortisone as adjunctive treatment of proliferative vitreoretinopathy. Br J Ophthalmol 84:1064\u20131067","journal-title":"Br J Ophthalmol"},{"key":"326_CR22","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/S0002-9394(00)00882-5","volume":"131","author":"JB Jonas","year":"2001","unstructured":"Jonas JB, Hayler JK, Sofker A, Panda-Jonas S (2001) Intravitreal injection of crystalline cortisone as adjunctive treatment of proliferative diabetic retinopathy. Am J Ophthalmol 131:468\u2013471","journal-title":"Am J Ophthalmol"},{"key":"326_CR23","first-page":"873","volume":"240","author":"JB Jonas","year":"2002","unstructured":"Jonas JB, Kreissig I, Degenring R (2002) Repeated intravitreal injections of triamcinolone acetonide as treatment of progressive exudative age-related macular degeneration. Graefes Arch Clin Exp Ophthalmol 240:873\u2013874","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"326_CR24","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1007\/s00417-002-0529-0","volume":"240","author":"JB Jonas","year":"2002","unstructured":"Jonas JB, Kreissig I, Degenring RF (2002) Intravitreal triamcinolone acetonide as treatment of macular edema in central retinal vein occlusion. Graefes Arch Clin Exp Ophthalmol 240:782\u2013783","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"326_CR25","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1016\/S0002-9394(03)00230-7","volume":"136","author":"JB Jonas","year":"2003","unstructured":"Jonas JB, Kreissig I, Degenring RF (2003) Intravitreal triamcinolone acetonide for pseudophakic cystoid macular edema. Am J Ophthalmol 136:384\u2013386","journal-title":"Am J Ophthalmol"},{"key":"326_CR26","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1136\/bjo.87.4.462","volume":"87","author":"JB Jonas","year":"2003","unstructured":"Jonas JB, Kreissig I, Hugger P, Sauder G, Panda-Jonas S, Degenring R (2003) Intravitreal triamcinolone acetonide for exudative age related macular degeneration. Br J Ophthalmol 87:462\u2013468","journal-title":"Br J Ophthalmol"},{"key":"326_CR27","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1001\/archopht.121.1.57","volume":"121","author":"JB Jonas","year":"2003","unstructured":"Jonas JB, Kreissig I, Sofker A, Degenring RF (2003) Intravitreal injection of triamcinolone for diffuse diabetic macular edema. Arch Ophthalmol 121:57\u201361","journal-title":"Arch Ophthalmol"},{"key":"326_CR28","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1001\/archopht.122.2.218","volume":"122","author":"JB Jonas","year":"2004","unstructured":"Jonas JB, Akkoyun I, Budde WM, Kreissig I, Degenring RF (2004) Intravitreal reinjection of triamcinolone for exudative age-related macular degeneration. Arch Ophthalmol 122:218\u2013222","journal-title":"Arch Ophthalmol"},{"key":"326_CR29","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1046\/j.1395-3907.2003.0146.x","volume":"81","author":"M Karacorlu","year":"2003","unstructured":"Karacorlu M, Ozdemir H, Karacorlu S (2003) Intravitreal triamcinolone acetonide for the treatment of chronic pseudophakic cystoid macular oedema. Acta Ophthalmol Scand 81:648\u2013652","journal-title":"Acta Ophthalmol Scand"},{"key":"326_CR30","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1097\/00006982-200312000-00028","volume":"23","author":"K Kumagai","year":"2003","unstructured":"Kumagai K (2003) Introduction of a new method for the preparation of triamcinolone acetonide solution as an aid to visualization of the vitreous and the posterior hyaloid during pars plana vitrectomy. Retina 23:881\u2013882","journal-title":"Retina"},{"key":"326_CR31","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1023\/A:1006016809070","volume":"22","author":"C Liang","year":"1998","unstructured":"Liang C, Peyman GA, Serracarbassa P, Calixto N, Chow AA, Rao P (1998) An evaluation of methylated collagen as a substitute for vitreous and aqueous humor. Int Ophthalmol 22:13\u201318","journal-title":"Int Ophthalmol"},{"key":"326_CR32","first-page":"1380","volume":"119","author":"A Martidis","year":"2001","unstructured":"Martidis A, Duker JS, Puliafito CA (2001) Intravitreal triamcinolone for refractory cystoid macular edema secondary to birdshot retinochoroidopathy. Arch Ophthalmol 119:1380\u20131383","journal-title":"Arch Ophthalmol"},{"key":"326_CR33","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1016\/S0161-6420(02)00975-2","volume":"109","author":"A Martidis","year":"2002","unstructured":"Martidis A, Duker JS, Greenberg PB, Rogers AH, Puliafito CA, Reichel E, Baumal C (2002) Intravitreal triamcinolone for refractory diabetic macular edema. Ophthalmology 109:920\u2013927","journal-title":"Ophthalmology"},{"key":"326_CR34","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/0002-9394(81)90013-1","volume":"91","author":"BW McCuen 2nd","year":"1981","unstructured":"McCuen BW 2nd, Bessler M, Tano Y, Chandler D, Machemer R (1981) The lack of toxicity of intravitreally administered triamcinolone acetonide. Am J Ophthalmol 91:785\u2013788","journal-title":"Am J Ophthalmol"},{"key":"326_CR35","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1016\/S0002-9394(03)00483-5","volume":"136","author":"DM Moshfeghi","year":"2003","unstructured":"Moshfeghi DM, Kaiser PK, Scott IU, Sears JE, Benz M, Sinesterra JP, Kaiser RS, Bakri SJ, Maturi RK, Belmont J, Beer PM, Murray TG, Quiroz-Mercado H, Mieler WF (2003) Acute endophthalmitis following intravitreal triamcinolone acetonide injection. Am J Ophthalmol 136:791\u2013796","journal-title":"Am J Ophthalmol"},{"key":"326_CR36","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1097\/00055735-200302000-00007","volume":"14","author":"ML Nelson","year":"2003","unstructured":"Nelson ML, Martidis A (2003) Managing cystoid macular edema after cataract surgery. Curr Opin Ophthalmol 14:39\u201343","journal-title":"Curr Opin Ophthalmol"},{"key":"326_CR37","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1097\/00006982-200312000-00005","volume":"23","author":"A Nishimura","year":"2003","unstructured":"Nishimura A, Kobayashi A, Segawa Y, Sakurai M, Shirao E, Shirao Y, Sugiyama K (2003) Isolating triamcinolone acetonide particles for intravitreal use with a porous membrane filter. Retina 23:777\u2013779","journal-title":"Retina"},{"key":"326_CR38","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/S0002-9394(03)00228-9","volume":"136","author":"CH Park","year":"2003","unstructured":"Park CH, Jaffe GJ, Fekrat S (2003) Intravitreal triamcinolone acetonide in eyes with cystoid macular edema associated with central retinal vein occlusion. Am J Ophthalmol 136:419\u2013425","journal-title":"Am J Ophthalmol"},{"key":"326_CR39","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1016\/j.ajo.2003.08.051","volume":"136","author":"DW Parke","year":"2003","unstructured":"Parke DW (2003) Intravitreal triamcinolone and endophthalmitis. Am J Ophthalmol 136:918\u2013919","journal-title":"Am J Ophthalmol"},{"key":"326_CR40","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1136\/bjo.86.6.600","volume":"86","author":"PL Penfold","year":"2002","unstructured":"Penfold PL (2002) Intravitreal triamcinolone in recurrence of choroidal neovascularisation. Br J Ophthalmol 86:600\u2013601","journal-title":"Br J Ophthalmol"},{"key":"326_CR41","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1111\/j.1442-9071.1995.tb00179.x","volume":"23","author":"PL Penfold","year":"1995","unstructured":"Penfold PL, Gyory JF, Hunyor AB, Billson FA (1995) Exudative macular degeneration and intravitreal triamcinolone. A pilot study. Aust N Z J Ophthalmol 23:293\u2013298","journal-title":"Aust N Z J Ophthalmol"},{"key":"326_CR42","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1097\/00006982-200005000-00024","volume":"20","author":"GA Peyman","year":"2000","unstructured":"Peyman GA, Cheema R, Conway MD, Fang T (2000) Triamcinolone acetonide as an aid to visualization of the vitreous and the posterior hyaloid during pars plana vitrectomy. Retina 20:554\u2013555","journal-title":"Retina"},{"key":"326_CR43","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1136\/bjo.86.5.527","volume":"86","author":"NT Ranson","year":"2002","unstructured":"Ranson NT, Danis RP, Ciulla TA, Pratt L (2002) Intravitreal triamcinolone in subfoveal recurrence of choroidal neovascularisation after laser treatment in macular degeneration. Br J Ophthalmol 86:527\u2013529","journal-title":"Br J Ophthalmol"},{"key":"326_CR44","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/S0002-9394(03)00389-1","volume":"136","author":"E Rechtman","year":"2003","unstructured":"Rechtman E, Allen VD, Danis RP, Pratt LM, Harris A, Speicher MA (2003) Intravitreal triamcinolone for choroidal neovascularization in ocular histoplasmosis syndrome. Am J Ophthalmol 136:739\u2013741","journal-title":"Am J Ophthalmol"},{"key":"326_CR45","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1001\/archopht.121.9.1279","volume":"121","author":"DB Roth","year":"2003","unstructured":"Roth DB, Chieh J, Spirn MJ, Green SN, Yarian DL, Chaudhry NA (2003) Noninfectious endophthalmitis associated with intravitreal triamcinolone injection. Arch Ophthalmol 121:1279\u20131282","journal-title":"Arch Ophthalmol"},{"key":"326_CR46","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1007\/s00417-002-0454-2","volume":"240","author":"T Sakamoto","year":"2002","unstructured":"Sakamoto T, Miyazaki M, Hisatomi T, Nakamura T, Ueno A, Itaya K, Ishibashi T (2002) Triamcinolone-assisted pars plana vitrectomy improves the surgical procedures and decreases the postoperative blood\u2013ocular barrier breakdown. Graefes Arch Clin Exp Ophthalmol 240:423\u2013429","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"326_CR47","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1016\/S0161-6420(03)00544-X","volume":"110","author":"RF Spaide","year":"2003","unstructured":"Spaide RF, Sorenson J, Maranan L (2003) Combined photodynamic therapy with verteporfin and intravitreal triamcinolone acetonide for choroidal neovascularization. Ophthalmology 110:1517\u20131525","journal-title":"Ophthalmology"},{"key":"326_CR48","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1001\/archopht.121.10.1491","volume":"121","author":"FK Sutter","year":"2003","unstructured":"Sutter FK, Gillies MC (2003) Intravitreal triamcinolone for radiation-induced macular edema. Arch Ophthalmol 121:1491\u20131493","journal-title":"Arch Ophthalmol"},{"key":"326_CR49","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1046\/j.1442-9071.2001.00360.x","volume":"29","author":"S Young","year":"2001","unstructured":"Young S, Larkin G, Branley M, Lightman S (2001) Safety and efficacy of intravitreal triamcinolone for cystoid macular oedema in uveitis. Clin Exp Ophthalmol 29:2\u20136","journal-title":"Clin Exp Ophthalmol"}],"container-title":["Graefe's Archive for Clinical and Experimental Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00417-006-0326-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00417-006-0326-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00417-006-0326-2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,27]],"date-time":"2021-07-27T11:21:41Z","timestamp":1627384901000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00417-006-0326-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,5,20]]},"references-count":49,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2006,11,8]]}},"alternative-id":["326"],"URL":"https:\/\/doi.org\/10.1007\/s00417-006-0326-2","relation":{},"ISSN":["0721-832X","1435-702X"],"issn-type":[{"value":"0721-832X","type":"print"},{"value":"1435-702X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,5,20]]}}}